6-9 September 2018 | Kaohsiung, Taiwan

20th Asia Pacific League of Associations for Rheumatology Congress

6-9 September 2018 | Kaohsiung, Taiwan

Masayoshi Harigai

Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases - Tokyo Women’s Medical University

Masayoshi Harigai, MD, PhD is Endowed Professor of Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Tokyo Women’s Medical University, Tokyo, Japan. He graduated from National Defense Medical College and received PhD from Keio University in 1991. He served as Professor of Department of Pharmacovigilance at Graduate School of Tokyo Medical and Dental University between 2007 and 2015. In 2015, he was installed in the present position. Professor Harigai is the principal investigator of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS) and of clinical trial of tocilizumab for ANCA-associated vasculitis.